Camlin Fine Sciences has informed that the Company has allotted 14,750 equity shares of face value of Re 1 each in accordance with the terms of ESOP 2018, on 15th March, 2023. Consequent to the said allotment the paid up share capital of the Company has gone up to 157093496 equity shares of face value of Re 1 each aggregating to Rs 15,70,93,496.
The above information is a part of company’s filings submitted to BSE.